Noninfectious Granulomatous Lung Disease: Radiological Findings and Differential Diagnosis.
Giulia LassandroStefano Giusto PicchiAntonio CorvinoCandida MassimoStefania TamburriniLaura VanoreGiovanna UrraroGiuseppe RussoFrancesco LassandroPublished in: Journal of personalized medicine (2024)
Granulomatous lung diseases (GLDs) are a heterogeneous group of pathological entities that can have different clinical presentations and outcomes. Granulomas are histologically defined as focal aggregations of activated macrophages, Langerhans cells, and lymphocytes, and may form in the lungs when the immune system cannot eliminate a foreign antigen and attempts to barricade it. The diagnosis includes clinical evaluation, laboratory testing, and radiological imaging, which especially consists of high-resolution computed tomography. bronchoalveolar lavage, transbronchial needle aspiration or cryobiopsy, positron emission tomography, while genetic evaluation can improve the diagnostic accuracy. Differential diagnosis is challenging due to the numerous different imaging appearances with which GLDs may manifest. Indeed, GLDs include both infectious and noninfectious, and necrotizing and non-necrotizing granulomatous diseases and the imaging appearance of some GLDs may mimic malignancy, leading to confirmatory biopsy. The purposes of our review are to report the different noninfectious granulomatous entities and to show their various imaging features to help radiologists recognize them properly and make an accurate differential diagnosis.
Keyphrases
- high resolution
- computed tomography
- positron emission tomography
- ultrasound guided
- clinical evaluation
- interstitial lung disease
- mass spectrometry
- type diabetes
- induced apoptosis
- adipose tissue
- magnetic resonance
- cell death
- metabolic syndrome
- rheumatoid arthritis
- signaling pathway
- fluorescence imaging
- fine needle aspiration
- cell proliferation
- systemic sclerosis
- peripheral blood
- skeletal muscle
- contrast enhanced
- endoplasmic reticulum stress
- idiopathic pulmonary fibrosis
- high speed
- dual energy
- glycemic control